if magic glp 1 Application of nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions I’ve recommended this smoothie to

By week 52, PINP levels had returned to their initial values in all groups ( Fig

doi:10.1016/j.molmet.2018.05.014 52

This means it could also potentially positively impact heart disease risk factors such as high blood pressure and high cholesterol

Off-Label Use: Some medications are prescribed off-label for weight loss: Semaglutide (Ozempic): FDA-approved for type 2 diabetes (not weight loss) Identical to Wegovy but different indication Commonly prescribed off-label for weight loss Same effectiveness as Wegovy Tirzepatide (Mounjaro): FDA-approved for type 2 diabetes (not weight loss) Identical to Zepbound but different indication Prescribed off-label for weight loss before Zepbound approval Same effectiveness as Zepbound Metformin: Diabetes medication sometimes used for weight loss Produces only 1-3% weight loss Not FDA-approved for weight loss Generally not recommended as primary weight loss medication The Current State of Weight Loss Medication: Clear Winners: GLP-1 receptor agonists (especially tirzepatide and semaglutide) have become the gold standard for medical weight loss, producing results previously unattainable with medication alone

Gut-Mediated Changes Enhance GLP-1 Secretion Given the potential role of gut microbiota in YM metabolism, ferulic acid and its microbial metabolite, dihydroferulic acid, were tested for their effects on GLP-1 secretion in GLUTag cells